Top Markets
#1 Siren Siren +33.39%
#2 Wiki Cat Wiki Cat +24.27%
#3 TRIA TRIA +18.72%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.15%
#5 PulseChain PulseChain +16.92%
#6 Bitway Bitway +15.87%
#7 Nockchain Nockchain +15.40%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.39%
#9 KUB Coin KUB Coin +14.81%
#10 Velvet Velvet +14.65%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Rank in Stocks #30950
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Share Price
$0.33274288
Market Cap
$14.92M
Change (1 day)
2.00%
Change (1 year)
-57.59%
Country
JP
Trade FunPep Company Limited (4881)

Category

Healthcare
P/B ratio for FunPep Company Limited (4881)
P/B ratio as of 2026 TTM: 0
According to FunPep Company Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for FunPep Company Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE